VF in the News

Amgen Successfully Completes Acquisition of ChemoCentryx

TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...

Read more

Mom Climbs Highest Mountain in Africa in Memory of Her Extraordinary Daughter

Update: Jo has made it to the top of Mt. Kilimanjaro! The climb was by far the hardest thing she’s ever had to face other than losing her daughter, Amy, to vasculitis. “They call it ‘The Roof of Africa’ but I call it almost to heaven! It’s the closest I’ll…...

Read more

2022 V-RED Winners

There’s something unique about the Vasculitis Foundation’s (VF’s) 2022 Recognizing Excellence in Diagnostics (V-RED) award program: We have two winners who tied for first place and two winners who received honorable mentions. Now in its ninth year, the V-RED award program calls on patients worldwide to nominate a medical professional…...

Read more

VF Board of Directors Welcomes Nona Bear

Nona is a nationally known advocate of healthcare reform and champion of seniors’ issues. Originally an academic who served on the faculties of several Washington-area universities including American, Howard, and George Mason, she was hired to establish a continuing education program at the U.S. Soldiers’ and Airmen’s Home, a facility…...

Read more